Serum IL-5 and IFN-γ Are Novel Predictive Biomarkers for Anti-PD-1 Treatment in NSCLC and GC Patients

BACKGROUND: Because responses of patients with cancer to immunotherapy can vary in success, effective biomarkers are urgently needed for predicting clinical response with anti-PD-1 treatment. We aimed to evaluate the IL-5 and IFN-γ level with the response of anti-PD-1 blockade in non-small-cell lung...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Qiu, Bi, Yanzhi, Sun, Huiting, Xiao, Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8235970/
https://www.ncbi.nlm.nih.gov/pubmed/34239620
http://dx.doi.org/10.1155/2021/5526885

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8235970/
https://www.ncbi.nlm.nih.gov/pubmed/34239620
http://dx.doi.org/10.1155/2021/5526885

Ejemplares similares